ACC Cracks After Third Quarter Earnings
Cement maker ACC Ltd. reported a revenue of Rs 2,470.5 crore for the July-September quarter, a decline of 7 percent from the same quarter last year. The figure was lower than the Bloomberg consensus estimate of Rs 2,657.6 crore.
Net profit fell 28.1 percent to Rs 84.10 crore from Rs 117 crore during the same quarter last year, according to its filing on the stock exchanges. This was significantly lower than analyst estimate of 188.4 crore. The fall in profits was due to a poor operating performances and higher interest costs.
Earnings before interest, tax, depreciation and amortisation fell 12.8 percent on a year-on-year basis to Rs 273.37 crore. EBITDA margins contracted 39 basis points to 10.85 percent from 11.24 percent during the same quarter last year due to an increase in employee expenses that increased 17.8 percent on a year-on-year basis.
Cement sales volume stood at 5.07 million tonne in this quarter versus 5.61 million tonne in corresponding quarter last year while sales realisations fell 1 percent.
Although higher monsoon activity subdued sales during the quarter, it augurs well for demand in the coming months as we maintained an optimistic outlook for the economy in coming months.ACC Statement
Market conditions led to marginally lower realisations compared to previous year in all regions except in north, whereas net selling prices registered an improvement on a sequential basis, the company added in its stock exchange filing.
Optimistic Outlook
The company remains optimistic on the demand scenario going forward, and expects to commission the remaining part of the Jamul integrated project by the end of this month, the company said in its filing.
On the supply side, we expect our volumes to pick up as the newly commissioned units stabilize, especially in the fast growing eastern regions. On the overall demand side, we maintain an optimistic outlook for the economy in the coming months.ACC Statement
Shares of the company fell as much as 4.09 percent to Rs 1,543 on the Bombay Stock Exchange - the lowest since June 14.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
